Sequenced treatment alternatives to relieve depression (STAR*D ... - PubMed
STAR*D is a multisite, prospective, randomized, multistep clinical trial of outpatients with nonpsychotic major depressive disorder. The study compares various treatment options for …
Sequenced Treatment Alternatives to Relieve Depression (STAR*D…
2008年2月25日 · The NIMH-funded Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study was conducted to determine the effectiveness of different treatments for …
Sequenced treatment alternatives to relieve depression (STAR*D ...
2004年2月1日 · STAR*D is a multisite, prospective, randomized, multistep clinical trial of outpatients with nonpsychotic major depressive disorder. The study compares various …
STAR*D - Wikipedia
Sequenced Treatment Alternatives to Relieve Depression (STAR*D) was a collaborative study on the treatment of depression, funded by the National Institute of Mental Health. Its main focus …
Questions and Answers about the NIMH Sequenced Treatment …
STAR*D aimed for the first time to provide solid scientific evidence regarding which next treatment steps are best for treatment-resistant depression. The results should produce clinical, …
The STAR*D Trial: It Is Time to Reexamine the Clinical Beliefs That ...
The STAR*D trial is the largest and most consequential antidepressant study ever conducted, with over 120 journal articles published by study investigators, innumerable citations of STAR*D’s …
二十年后，重新设计抑郁症的STAR×D研究｜专家视角
2022年2月18日 · 抑郁症的序贯治疗研究（STAR*D）于2001年启动，是精神医学的里程碑之一，被视为理解真实世界临床转归的三大有效性研究之一。 STAR*D研究旨在解决抑郁症「下一 …
Relieve Depression (STAR*D) study, the largest prospective clinical trial of treatment of major depressive disorder ever conducted. It was funded by the National Institutes of Health and …
The sequenced treatment alternatives to relieve depression (STAR*D …
Objective: The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial is the largest open-label, pragmatic trial that has been undertaken to examine the treatment of major …
STAR*D differs from standard RCTs in 6 key ways. The first 3 pertain to study generalizability; that is, broad inclusion criteria with few exclusion criteria, the integration of patient choice, and …